Organization Overview
Historical Acquisition Tree
Alternative names
cabozantinib (cometriq) (2012 NDA)
bortezomib (velcade) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (1 trial)
cobimetinib (cotellic) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Follicular (Phase 2)
Adrenocortical Carcinoma (Phase 2)
Albuminuria (Phase 2)
Astrocytoma (Phase 2)
Bile Duct Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Neuroendocrine (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Papillary (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Carotid Body Tumor (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Diabetic Nephropathies (Phase 2)
Digestive System Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 1)
Gastrointestinal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 1)
Hematologic Neoplasms (Phase 2)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 2)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 2)
Neuroendocrine Tumors (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1)
Paraganglioma (Phase 2)
Pheochromocytoma (Phase 2)
Philadelphia Chromosome (Phase 1)
Polycythemia (Phase 1)
Polycythemia Vera (Phase 1)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 3)
Renal Insufficiency (Phase 1)
Sarcoma (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 1)
Thrombocythemia, Essential (Phase 1)
Thrombocytosis (Phase 1)
Thyroid Cancer, Papillary (Phase 2)
Thyroid Diseases (Phase 4)
Thyroid Neoplasms (Phase 4)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urologic Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)